Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS: A double-blind, randomized trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine

Annals of Internal Medicine

Volumn 124, Issue 9, 1996, Pages 792-802

  Safrin, Sharon ^a   Finkelstein, Dianne M ^b   Feinberg, Judith ^c   Frame, Peter ^d   Simpson, Gail ^e   Wu, Albert ^f   Cheung, Tony ^g   Soeiro, Ruy ^h   Hojczyk, Peter ⁱ   Black, John R ^e  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^e Johns Hopkins School of Medicine ^*  (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

ⁱ FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; PREDNISONE; PRIMAQUINE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANTIBIOTIC THERAPY; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHEMOGLOBINEMIA; MULTICENTER STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; DAPSONE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HEMATOLOGIC DISEASES; HUMANS; MALE; PNEUMONIA, PNEUMOCYSTIS; PRIMAQUINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TREATMENT FAILURE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0030005029     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-9-199605010-00003     Document Type: Review

References (29)

1. National Center for Infectious Diseases. HIV/AIDS Surveillance Report Atlanta U S Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, National Center for Infectious Diseases, Division of HIV/AIDS: CDC National AIDS Clearinghouse; 1994 1-36.
2. Wharton JM, Coleman DL, Wofsy CB, Luce JM, Blumenfeld W, Hadley WK, et al. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome A prospective randomized trial. Ann Intern Med 1986,105 37-44
3. Klein NC, Duncanson FP, Lenox TH, Forszpaniak C, Sherer CB, Quentzel H, et al. Trimethoprim-sulfamethoxazole versus pentamidine for Pneumocystis carinii pneumonia in AIDS patients: results of a large prospective randomized treatment trial AIDS 1992;6:301-5.
4. Sattler FR, Cowan R, Nielsen DM, Ruskin J. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome A prospective, noncross-over study. Ann Intern Med. 1988,109 280-7
5. Medina I, Mills J, Leoung G, Hopewell PC, Lee B, Modin G, et al. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone N Engl J Med 1990;323:776-82.
6. Toma E, Fournier S, Dumont M, Bolduc P, Deschamps H. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind pilot trial Clin Infect Dis 1993,17 178-84
7. Hughes W, Leoung G, Kramer F, Bozzette SA, Safrin S, Frame P, et al. Comparison of atovaquone (566C80) with trimethoprim-sulfamethoxazole to treat Pneumocystis carinii pneumonia in patients with AIDS N Engl J Med. 1993,328 1521-7
8. Sattler FR, Frame P, Davis R, Nichols L, Shelton B, Akil B, et al. Trimetrexate with leucovorin versus trimethoprim-sulfamethoxazole for moderate to severe episodes of Pneumocystis carinii pneumonia in patients with AIDS a prospective, controlled multicenter investigation of the AIDS Clinical Trials Group Protocol 029/031. J Infect Dis. 1994,170 165-72
9. Leoung GS, Mills J, Hopewell PC, Hughes W, Wofsy C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome Ann Intern Med 1986;105:45-8
10. Queener SF, Bartlett MS, Richardson JD, Durkin MM, Jay MA, Smith JW. Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother. 1988;32:807-13.
11. Toma E, Poisson M, Fournier M, Morisset R, Phaneuf D, Vega C. Clindamycin with primaquine for Pneumocystis carinii pneumonia Lancet. 1989;1 1046-8.
12. Kay R, DuBois RE. Clindamycin/primaquine therapy and secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS South Med J 1990;83 403-4
13. Toma E. Clindamycin/primaquine for treatment of Pneumocystis carinii pneumonia in AIDS Eur J Clin Microbiol Infect Dis. 1991;10.210-3
14. Ruf B, Rohde I, Pohle HD. Efficacy of clindamycin/primaquine versus trimethoprim/sulfamethoxazole in primary treatment of Pneumocystis carinii pneumonia. Eur J Clin Microbiol Infect Dis. 1991;10:207-10
15. Black JR, Feinberg J, Murphy RL, Pass RJ, Finkelstein D, Akil B, et al. Clindamycin and primaquine therapy for mild-to-moderate episodes of Pneumocystis carinii pneumonia in patients with AIDS AIDS Clinical Trials Group 044. Clin Infect Dis 1994,18:905-13
16. Toma E, Fournier S, Dumont M, Bolduc P, Deschamps H. Clindamycin/primaquine versus trimethoprim-sulfamethoxazole as primary therapy for Pneumocystis carinii pneumonia in AIDS: a randomized, double-blind trial Clin Infect Dis 1993;17 178-84.
17. Consensus statement on the use of corticosteroids as adjunctive therapy for pneumocystis pneumonia in the acquired immunodeficiency syndrome The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia N Engl J Med. 1990,323 1500-4
18. Hlatky MA, Boineau RE, Higgenbotham MB, Lee KL, Mark DB, Califf RM, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index) Am J Cardiol 1989,64:651-4.
19. Wu AW, Rubin HR, Mathews WC, Ware JE Jr, Brysk LT, Hardy WD, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care. 1991;29:786-98.
20. Stewart AL, Hays RD, Ware JE. Health perceptions and energy/fatigue In Stewart AL, Ware JE, eds. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC Duke Univ Pr; 1992
21. Ries PW. Current estimates from the National Health Interview Survey, United States 1984. Data from the National Health Survey Series 10, No 156. DHHS publication no (PHS) 86-1584, Bethesda, MD: U S Department of Health and Human Services, 1986
22. Rubin HR, Wu AW, Gutierrez M, Liriano O, Safrin S. Spanish translation of a functional status questionnaire for pneumocystis carinii pneumonia VIII International Conference on AIDS/III STD World Congress, Amsterdam, the Netherlands, 1992
23. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982,38:963-74
24. Safrin S, Lee BL, Sande MA. Adjunctive folinic acid with trimethoprimsulfamethoxazole for Pneumocystis carinii pneumonia in AIDS patients is associated with an increased risk of therapeutic failure and death J Infect Dis. 1994,170:912-7
25. Garay SM, Greene J. Prognostic indicators in the initial presentation of Pneumocystis carinii pneumonia Chest 1989,95 769-72.
26. Safrin S. Pneumocystis carinii infection. In. Stein JH, ed. Internal Medicine 4th ed St Louis Mosby, 1994.2270-4
27. Stevens RC, Laizure SC, Williams CL, Stein DS. Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects Antimicrob Agents Chemother. 1991;35: 1884-90
28. Bowden FJ, Harman PJ, Lucas CR. Serum trimethoprim and sulphamethoxazole levels in AIDS [Letter] Lancet 1986,1:853
29. Lee BL, Medina I, Benowitz NL, Jacob P 3d, Wofsy CB, Mills J 5th. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS) Evidence of drug interactions. Ann Intern Med. 1989;110. 606-11.